Best-selling Ophthalmic Drugs in China | Market Wrap 2021

by Grace Wang Jan 10, 2022

The year 2021 has seen a remarkable growth of the ophthalmic drug market in China. The market size of chemical drugs for eye diseases is estimated to exceed 3.5 billion yuan (circa 549 million USD), with a year-on-year growth of 1.89%.1

Ophthalmic Drugs: Market Numbers 

Among the best-selling eye disease drugs, Naphazoline Hydrochloride, Chlorphenamine Maleate and Vitamin B12 Eye Drops took the champion with over 400 million yuan (about 62.76 million USD) in sales value.

There are 13 ophthalmic drugs which realizes more than 100 million yuan (about 15.68 million USD) in sales. The top four are all for relieving dry or tired eyes. Bendazac Lysine Eye Drops, for treating early-stage senile cataract, ranked the fifth. The other eight are mainly antibiotic eye drops.

Grace Wang
ChemLinked Regulatory Analyst
Copyright: unless otherwise stated all contents of this website are ©2022 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact